TP53TG3B

Across TCGA pan-cancer cohorts, TP53TG3B RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated TP53TG3B data layer.

The strongest signal is observed in small cell lung cancer (SCLC), where higher TP53TG3B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TP53TG3B expression acts as an unfavorable survival marker.

SCLC are the cancer types where TP53TG3B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Tertile	III,IV	0.313	0.728	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

TP53TG3B–SCLC (OS)

Open the SCLC breakdown →